| Pharmaceutical active ingredients: |
| Benzoxonium ChlorideLidocaine Hydrochloride |
| Available forms, composition and doses of TheraFlu LAR: |
| Spray; Nasal; Benzoxonium Chloride 2 mg; Lidocaine Hydrochloride 1.5 mg / mlTablets, Orally Disintegrating; Oral; Benzoxonium Chloride 1 mg; Lidocaine Hydrochloride 1 mgTablets; Oral; Benzoxonium Chloride 1 mg; Lidocaine Hydrochloride 1 mg |
| TheraFlu LAR medical category: |
| Human |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| R02AA20 - Antiseptics, various |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Novartis |